大肠杆菌亮氨酰—tRNA合成酶基因表达和酶的纯化

在克隆含大肠杆菌氨酰－ｔＲＮＡ合成酶基因的３．２ｋｂＤＮＡ片段,并ｌｅｕＳ在大肠杆菌和中高表达提高３５倍的基础上ｌｅｕＳ改造,分别将两处不同长度的ｌｅｕＳ１和ｌｅｕＳ２分别构建在表达载体ＰＫＫ－２３３－２和ｐＴｒｃ－９９Ｂ中,其中ｌｅｕＳ１比ｌｅｕＳ２多一段１３０ｂｐ的３非翻译区。构建在表达载体ｐＴｒｃ－９９Ｂ中的基因片段ｌｅｕ３２可将酶的表达量提高１３５倍,经ＤＥＡＥ－Ｓｅｐｈａｒｏｓｅ和ＨＡ－     

大肠杆菌亮氨酰tRNA合成酶基因的克隆和鉴定

本文根据遗传互补原理,利用肠杆菌亮氨－ｔＲＮＡ合成酶基因的温度敏感突变株ＫＬ２３１,从大肠杆菌基因文库－克隆中筛选出带完整ＬｅｕＳ基因的ＤＮＡ片段。该片段长长度为３．２ｋｂ。对此片段做了１４种限制性内切酶图谱分析和部分ＤＮＡ序列鉴定,并与文献报道的ＬｅｕＳ基因序列进行了比较。发现在编码区和３＇端非编码区各有一对碱基发生了转换,另外在３＇端非编码区有一对碱基缺失。编码区的碱基对转换导致编码的氨基酸由     

大肠杆菌亮氨酰—tRNA合成酶LeuRS67R的纯化及其动力学研究

本实验室已得到的亮氨酰－ｔＲＮＡ合成酶基因,与文献相比,６７位氨基酸残基由Ｈｉｓ变为Ａｒｇ,此酶被定名为ＬｅｕＲＳ６７Ｒ。我们从该基因与ｐＵＣ１９重组质粒的大肠杆菌ＴＧ１转化子ＴＧ１－９１中得到ＬｅｕＲＳ的高表达,粗抽液中ＬｅｕＲＳ的表达量在转化子中比在宿主菌ＴＧ１中高２０倍以上。用三步柱层析得到电泳一条带的酶,其比活为１７８９单位／毫克。测定其动力学常数,氨酰化活力为Ｌｅｕ、ＡＴＰ的Ｋｍ值分别为     

氨酰tRNA 合成酶抑制剂作为新型抗感染药物的研究进展

细菌耐药性的不断上升对现有阶段的抗生素类药物提出了一个严峻的挑战,同时也掀起了针对于新靶标的抗菌药物的研究。氨酰tRNA合成酶(aaRS)催化特定氨基酸连接到相应的tRNA分子上,在蛋白质的合成过程中起着必不可少的作用。氨酰tRNA合成酶的抑制会导致蛋白质合成的停止,扰乱细菌和真菌的生长,因此氨酰tRNA合成酶是一类潜在的抗感染靶标。本文分别综述了天然产物及其衍生的aaRS抑制剂,底物和反应中间体模拟物,通过合成和通过虚拟筛选得到的aaRS抑制剂作为新型抗细菌和抗真菌药物的研究进展,并对aaRS的靶标特点、分类和催化机制作一简要介绍。     

大肠杆菌亮氨酰－tRNA合成酶LeuRS67R的纯化及其动力学研究

本实验室已得到的亮氨酰－ｔＲＮＡ合成酶（ＬｅｕＲＳ）基因,与文献相比,６７位氨基酸残基由Ｈｉｓ变为Ａｒｇ,此酶被定名为ＬｅｕＲＳ６７Ｒ。我们从该基因与ｐＵＣ１９重组质粒的大肠杆菌ＴＧ１转化子ＴＧ１－９１中得到ＬｅｕＲＳ的高表达,粗抽液中ＬｅｕＲＳ的表达量在转化子中比在宿主菌ＴＧ１中高２０倍以上。用三步拉层析得到电泳一条带的酶,其比活为１７８９单位／毫克。测定其动力学常数,氨酰化活力对Ｌｅｕ、ＡＴＰ的Ｋｍ值分别为０．０２７ｍｍｏｌ／Ｌ、０．４７ｍｍｏｌ／Ｌ,Ｋｃａｔ值分别为３．５～５．１ｓ－１。ＡＴＰ－ＰＰｉ交换活力对Ｌｅｕ、ＡＴＰ的Ｋｍ值分别为０．０３ｍｍｏｌ／Ｌ、１．０ｍｍｏｌ／Ｌ,Ｌｃａｔ值分别为１４０～１５５ｓ－１。此结果与从野生型大肠杆菌Ｋ－１２中提纯的ＬｅｕＲＳ的动力学常数差别很小,６７位氨基酸残基在与活性中心无直接关系的域可能是大肠杆菌的种间差异。     

氨酰-tRNA合成酶对tRNA的识别

氨酰-tRNA合成酶(aaRS)与tRNA的相互作用保证了蛋白质生物合成的忠实性. 氨酰-tRNA合成酶对tRNA识别的专一性依赖于aaRS特定的催化结构域和tRNA分子特异的三级结构构象. 反密码子和接受茎(包括73位)在大多数aaRS对tRNA分子的识别过程中起着关键作用, 其他部位如可变口袋、可变(茎)环等, 甚至修饰核苷酸对于一些识别过程也有重要作用.     

氨酰tRNA合成酶作用机制及其应用

氨酰tRNA合成酶（aminoacyl tRNA synthetases, aaRSs）通过催化氨基酸与相应tRNA的氨酰化以保证遗传信息翻译的准确性,在生物体内具有重要作用。近年来,随着对aaRS催化机制理解的不断加深,aaRS的应用逐渐成为研究热点。在细菌中,aaRS活性被抑制后会导致其生命活动发生紊乱,根据aaRS在人体与病原菌内不同的催化特点设计针对病原体的特异性aaRS抑制剂,将有助于开发以aaRS为靶标的新型抗生素。另外,通过突变aaRS可以在蛋白质序列中定点掺入非天然氨基酸,扩展蛋白质工程。本文简述了aaRS的分类、结构与功能的特点,并在此基础上综述了aaRS在研发新型抑制剂,设计改造特殊蛋白质等方面的应用。     

大肠杆菌精氨酰tRNA合成酶基因的诱导高表达

在高表达大肠杆菌精氨酰ｔＲＮＡ合成酶基因５５０倍的基础上,将ａｒｇ２的编码起始位点经基因突点突变导入ＮｃｏＩ限制性内切酶的位点后,重组到受异丙基硫代－β－Ｄ半乳糖苷诱导的ｐＴｒ９９Ｂ质粒上,使ａｒｇＳ比受体菌表达高近２０００倍。通过一步ＤＥＡＥ－Ｓｅｐｈａｒｏｓｅ柱层析则可得到ＳＤＳ－ＰＡＧＥ一条带的ＡｒｇＲＳ,比活为１５０００ｕ／ｍｇ,与文献相同。     

氨酰tRNA合成酶作用机制及其应用北大核心CSCD

氨酰tRNA合成酶(aminoacyl-tRNA synthetases,aaRSs)通过催化氨基酸与相应tRNA的氨酰化以保证遗传信息翻译的准确性,在生物体内具有重要作用。近年来,随着对aaRS催化机制理解的不断加深,aaRS的应用逐渐成为研究热点。在细菌中,aaRS活性被抑制后会导致其生命活动发生紊乱,根据aaRS在人体与病原菌内不同的催化特点设计针对病原体的特异性aaRS抑制剂,将有助于开发以aaRS为靶标的新型抗生素。另外,通过突变aaRS可以在蛋白质序列中定点掺入非天然氨基酸,扩展蛋白质工程。本文简述了aaRS的分类、结构与功能的特点,并在此基础上综述了aaRS在研发新型抑制剂,设计改造特殊蛋白质等方面的应用。     

Quantitative Ultrastructural Differences between Strains of the Trypanosoma brucei Subgroup During Transformation in Blood*

SYNOPSIS. Differences in the relative and absolute cell organization between strains of the Trypanosoma brucei subgroup were studied during the transformation from slender to stumpy bloodforms. Two pleomorphic and 1 monomorphic T. b. brucei, and 1 pleomorphic T. b. rhodesiense strains were investigated. Volume densities, surface densities and surface to volume ratios showed barely significant differences between the 2 pleomorphic T. b. brucei strains; absolute parameters, however, differ markedly between all the strains investigated. Only the relative parameters of the mitochondrion show notable differences between T. b. brucei and T. b. rhodesiense examined here. During the transformation from slender to stumpy forms the enlargement of the mitochondrial volume in T. b. brucei is achieved by an increase in width of the mitochondrial tube and in T. b. rhodesiense by the formation of a more elaborate network. The ratio of the inner mitochondrial membrane surface area to the mitochondrial matrix volume showed no significant change in all 3 pleomorphic strains examined. Because of their morphometric similarity to slender forms of pleomorphic T. b. brucei strains, it can be assumed that the monomorphic trypanosomes correspond morphologically to slender trypanosomes. Neither pleomorphism nor strain specificity have a significant influence on the relative amount of “vesicles” and lipid inclusions.     

Selective Transport of a New Class of Purine Antimetabolites by the Protozoan Parasite Trypanosoma brucei

Purine antimetabolites have been very successful therapeutic agents against a host of infectious diseases and malignancies. Success of the treatment relies as much on the efficient accumulation by the target cell or organism as it does on selective action on a vital biochemical pathway of the target cell. Here we compare the ability of a new class of tricyclic purine antimetabolites to interact with transporters from human erythrocytes or Trypanosoma brucei. We show that these compounds display a remarkable selectivity for the parasite's transporters. The adenine analogue showed greater trypanocidal activity than the hypoxanthine or guanine analogues in vitro.     

A proteomic analysis of arsenical drug resistance in Trypanosoma brucei

We have undertaken 2-DE and MS to identify proteins associated with arsenical drug resistance in Trypanosoma brucei. This parasite causes sleeping sickness in humans, and arsenical drug resistance is a significant potential problem. Comparative analysis of approximately 2000 spots resolved by 2-DE in the soluble proteomes of drug-sensitive and drug-resistant isogenic lines of T. brucei identified a protein spot whose absence associated with resistance to the arsenical drug, Cymelarsan. MS matched this protein to an identical pair of tandem genes Tb09.211.0120 and 0130 that encode a putative nascent polypeptide associated complex subunit. This protein also occurs as an isoform located in both resistant and sensitive lines at a similar molecular weight, but different pI. The difference between isogenic lines was confirmed by Western blot using an antibody against recombinant protein. Both genes were identical in sequence between drug-sensitive and drug-resistant lines and both were transcribed as determined by RT-PCR. We postulate that the missing protein isoform arose due to the lack of a PTM.     

An Essential Type I Nitroreductase from Leishmania major Can Be Used to Activate Leishmanicidal Prodrugs

Nitroaromatic prodrugs are used to treat a range of microbial infections with selectivity achieved by specific activation reactions. For trypanosomatid parasites, this is mediated by type I nitroreductases. Here, we demonstrate that the causative agent of leishmaniasis, Leishmania major, expresses an FMN-containing nitroreductase (LmNTR) that metabolizes a wide range of substrates, and based on electron donor and acceptor preferences, it may function as an NADH:quinone oxidoreductase. Using gene deletion approaches, we demonstrate that this activity is essential to L. major promastigotes, the parasite forms found in the insect vector. Intriguingly, LmNTR^+/− heterozygote promastigote parasites could readily differentiate into infectious metacyclic cells but these were unable to establish infections in cultured mammalian cells and caused delayed pathology in mice. Furthermore, we exploit the LmNTR activity evaluating a library of nitrobenzylphosphoramide mustards using biochemical and phenotypic screens. We identify a subset of compounds that display significant growth inhibitory properties against the intracellular parasite form found in the mammalian hosts. The leishmanicidal activity was shown to be LmNTR-specific as the LmNTR^+/− heterozygote promastigotes displayed resistance to the most potent mustards. We conclude that LmNTR can be targeted for drug development by exploiting its prodrug activating property or by designing specific inhibitors to block its endogenous function.     

Quantitative Ultrastructural Investigations of the Life Cycle of Trypanosoma brucei: A Morphometric Analysis*

SYNOPSIS. The quantitative ultrastructure of the developmental stages of Trypanosoma brucei brucei in its vector Glossina morsitans was studied by morphometric analysis. Values from ectoperitrophic midgut forms, proventricular forms, epimastigote and metacyclic forms in the salivary gland are compared with results from bloodstream forms, published previously. Significant differences in the volume densities of the trypanosome's single mitochondrion, of microbody-like organelles and in the surface densities of inner and outer mitochondrial membranes were found throughout the whole life cycle. A great increase in volume density of the mitochondrion was observed after transfer to the insect host; reduction took place during metacyclic development. Parallel to the biogenesis of the mitochondrion a reduction of microbodies was found in proventricular forms and there was a great increase in metacyclic forms concomitant with the regression of the mitochondrion. Metacyclic forms had a close quantitative morphologic similarity to bloodstream forms. The results are discussed in connection with changes in structure and in oxidative metabolism.     

Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal,cytotoxic and genotoxic activities and their in vitro and in silico interactions with the Trypanosoma brucei nitroreductase enzyme

Megazol (7) is a 5-nitroimidazole that is highly active against Trypanosomacruzi and Trypanosoma brucei, as well as drug-resistantforms of trypanosomiasis. Compound 7 is not used clinically due to its mutagenic andgenotoxic properties, but has been largely used as a lead compound. Here, we comparedthe activity of 7 with its 4H-1,2,4-triazole bioisostere (8) inbloodstream forms of T. brucei and T. cruzi andevaluated their activation by T. brucei type I nitroreductase(TbNTR) enzyme. We also analysed the cytotoxic and genotoxiceffects of these compounds in whole human blood using Comet and fluoresceindiacetate/ethidium bromide assays. Although the only difference between 7 and 8 isthe substitution of sulphur (in the thiadiazole in 7) for nitrogen (in the triazolein 8), the results indicated that 8 had poorer antiparasitic activity than 7 and wasnot genotoxic, whereas 7 presented this effect. The determination of Vmax indicatedthat although 8 was metabolised more rapidly than 7, it bounds to theTbNTR with better affinity, resulting in equivalent kcat/KMvalues. Docking assays of 7 and 8 performed within the active site of a homologymodel of the TbNTR indicating that 8 had greater affinity than7.